WebbPieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s clinical pipeline includes an inhaled IL-4Rα antagonist Anticalin protein to treat asthma, an immuno-oncology (IO), bispecific targeting HER2 and 4-1BB, and an IO ... WebbPieris Pharmaceuticals to Present at Jefferies London Healthcare Conference. Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company …
PIRS Pieris Pharmaceuticals Inc - Stocktwits
Webb26 apr. 2024 · Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, … WebbPIRS Growth Metrics. The 4 year cash and equivalents growth rate now stands at -14.14%. Its year over year price growth rate is now at -6.77%. The 5 year net income to common stockholders growth rate now stands at 19.09%. Over the past 33 months, PIRS's revenue has gone down $17,780,000. The table below shows PIRS's growth in key financial ... krung thai bank thailand swift code
PIRS news, real time PIRS stock news, Pieris Pharmaceu news today - Webull
Webb5 nov. 2024 · Pieris Pharmaceuticals Inc announced earnings per share of $-0.130 on revenue of $5.37M. Analysts polled by Investing.com anticipated EPS of $-0.105 on … WebbPIRS is a small specialized commercial collection agency by choice, servicing a select clientele. We utilize state of the art technology and equipment and employ only the most … Webb30 mars 2024 · Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) concluded the trading at $1.06 on Wednesday, March 29 with a fall of -28.38% from its closing price on previous day. … krung thai bank plc thailand swift code